We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$650M
AUM Growth
-$107M
Cap. Flow
-$73.7M
Cap. Flow %
-11.34%
Top 10 Hldgs %
28.5%
Holding
529
New
249
Increased
8
Reduced
22
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 11.86%
3 Technology 7.97%
4 Industrials 4.89%
5 Communication Services 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDACU
201
DELISTED
Sustainable Development Acquisition I Corp. Unit
SDACU
$746K 0.11%
+75,000
New +$784K
BOAS.U
202
DELISTED
BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant
BOAS.U
$743K 0.11%
+75,000
New +$749K
HCIIU
203
DELISTED
Hudson Executive Investment Corp. II Unit
HCIIU
$736K 0.11%
+75,000
New +$780K
POW
204
DELISTED
Powered Brands Class A Ordinary Shares
POW
$729K 0.11%
+74,994
New +$730K
ROT.U
205
DELISTED
Rotor Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of
ROT.U
$701K 0.11%
+70,000
New +$723K
FRXB.U
206
DELISTED
Forest Road Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
FRXB.U
$697K 0.11%
+70,000
New +$703K
PLLL
207
DELISTED
Piedmont Lithium Limited American Depositary Receipts
PLLL
$695K 0.11%
+10,000
New +$695K
WGSWW
208
DELISTED
GeneDx Holdings Warrant
WGSWW
$691K 0.11%
133,332
DBTX
209
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$652K 0.1%
+57,401
New +$901K
TPST icon
210
Tempest Therapeutics
TPST
$16.6M
$600K 0.09%
+2,564
New +$1.04M
LCIDW
211
DELISTED
Lucid Group, Inc. Warrant
LCIDW
$557K 0.09%
49,998
WPCA.U
212
DELISTED
Warburg Pincus Capital Corporation I-A Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCA.U
$504K 0.08%
+50,000
New +$505K
ACTDU
213
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
$500K 0.08%
+50,000
New +$500K
LOKM.U
214
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
$499K 0.08%
+50,000
New +$509K
PDOT.U
215
DELISTED
Peridot Acquisition Corp. II Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PDOT.U
$497K 0.08%
+50,000
New +$497K
PPGH
216
DELISTED
Poema Global Holdings Corp. Class A Ordinary Share
PPGH
$489K 0.08%
+49,998
New +$489K
SRZN icon
217
Surrozen
SRZN
$295M
$481K 0.07%
+3,333
New +$508K
BVS icon
218
Bioventus
BVS
$1.17B
$458K 0.07%
+30,000
New +$427K
AGTC
219
DELISTED
Applied Genetic Technologies Corporation
AGTC
$455K 0.07%
+250,000
New +$1.3M
CEREW
220
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$431K 0.07%
99,998
SCLEU
221
DELISTED
Broadscale Acquisition Corp. Units
SCLEU
$427K 0.07%
+43,069
New +$439K
JIH.WS
222
DELISTED
Juniper Industrial Holdings, Inc. Redeemable warrants included as part of the units
JIH.WS
$413K 0.06%
150,000
ATCX
223
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$409K 0.06%
40,103
GTPBU
224
DELISTED
Gores Technology Partners II, Inc. Units
GTPBU
$399K 0.06%
+40,000
New +$404K
VCVCW
225
DELISTED
10X Capital Venture Acquisition Corp Warrant
VCVCW
$358K 0.06%
+199,999
New +$508K

Similar funds

Monashee Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Monashee Investment Management held 529 positions worth $650M, down 14% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Monashee Investment Management withdrew a net $73.7M in Q1 2021, closing 155 positions and reducing 22 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Beam Therapeutics worth $21.5M.

  • Monashee Investment Management's largest Q1 2021 buy was Beam Therapeutics: 268,820 shares worth $21.5M.
  • Monashee Investment Management added most to View, Inc. Class A Common Stock in Q1 2021, an estimated $11.9M increase.
  • Monashee Investment Management's biggest Q1 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $53.1M.
  • Monashee Investment Management fully exited Sigilon Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27M.
  • Monashee Investment Management's ten largest holdings make up 28% of its $650M portfolio in Q1 2021.
  • Monashee Investment Management opened 249 new positions and closed 155 in Q1 2021.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $650M.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.